tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Karyopharm backs FY25 revenue view $140M-$155M, consensus $147.08M
PremiumThe FlyKaryopharm backs FY25 revenue view $140M-$155M, consensus $147.08M
27d ago
Is KPTI a Buy, Before Earnings?
Premium
Pre-Earnings
Is KPTI a Buy, Before Earnings?
29d ago
Karyopharm downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Karyopharm downgraded to Neutral from Buy at H.C. Wainwright
2M ago
Karyopharm abstract selected for presentation at 2025 EHA meeting
PremiumThe FlyKaryopharm abstract selected for presentation at 2025 EHA meeting
4M ago
Karyopharm price target lowered to $33 from $43 at RBC Capital
Premium
The Fly
Karyopharm price target lowered to $33 from $43 at RBC Capital
4M ago
Karyopharm price target lowered to $42 from $54 at Baird
Premium
The Fly
Karyopharm price target lowered to $42 from $54 at Baird
4M ago
KPTI Earnings this Week: How Will it Perform?
PremiumPre-EarningsKPTI Earnings this Week: How Will it Perform?
4M ago
Biotech stocks slide as Marks resignation seen being negative for sector
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
5M ago
Marks resignation ‘not good’ for biotech sector, says RBC
Premium
The Fly
Marks resignation ‘not good’ for biotech sector, says RBC
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100